AstraZeneca (Pfizer Bid) Debate

Full Debate: Read Full Debate
Tuesday 6th May 2014

(10 years ago)

Commons Chamber
Read Full debate Read Hansard Text

Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.

Each Urgent Question requires a Government Minister to give a response on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Vince Cable Portrait Vince Cable
- Hansard - - - Excerpts

Of course, we will take that into account as part of our assessment in the national interest. Our starting point is the strength of the UK science base and our manufacturing industry, but there are positive potential implications for tax and for the flow of capital.

Andrew Love Portrait Mr Andrew Love (Edmonton) (Lab/Co-op)
- Hansard - -

I understand the constraints on the Secretary of State, but is he not concerned about the track record of Pfizer in this area—significantly less research and development than AstraZeneca, recent cuts and the closure of the Sandwich plant, with all the broken promises that that entailed? Does that not lead him to think that the Government should have a role in this matter, and will he invoke a public interest test to achieve that?

Vince Cable Portrait Vince Cable
- Hansard - - - Excerpts

Of course there is a role for Government, which is why my colleagues and I have been talking to the two companies and why we are trying to obtain the strongest possible commitment to the UK science base.